Modelling the potential longterm survival benefit of evinacumab treatment vs standard of care in patients with homozygous familial hypercholesterolaemia

Simple item page
dc.article.end-page1880en
dc.article.start-page1874en
dc.citation.doi10.1093/EURJPC/ZWAD203en
dc.contributor.authorJ Guen
dc.contributor.authorA Kuzniken
dc.contributor.authorP Quonen
dc.contributor.authorA Chauhanen
dc.contributor.authorTupili S Sravyaen
dc.contributor.authorFrederick Raalen
dc.date.accessioned2024-07-23T05:56:10Z
dc.date.available2024-07-23T05:56:10Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2047-4873en
dc.identifier.urihttps://hdl.handle.net/10539/39191
dc.journal.titleModelling the potential longterm survival benefit of evinacumab treatment vs standard of care in patients with homozygous familial hypercholesterolaemiaen
dc.journal.volume30en
dc.titleModelling the potential longterm survival benefit of evinacumab treatment vs standard of care in patients with homozygous familial hypercholesterolaemiaen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Journal Article.pdf
Size:
576 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)